EUVIMEDEUVIMED entdecken
Crossref

Annexin A1/FPR2 pathway modulates leukocyte function during Escherichia coli ‐induced pneumonia to promote resolution of inflammation and restores lung function

Edvaldo S Lara iD, Antônio Felipe S Carvalho iD, Camila Cardoso iD, Isabella Zaidan iD, Laís C Grossi iD, Fernanda S Carneiro iD, Erick Bryan S Lima iD, Adelson Heric A Monteiro iD, Rodrigo S Caixeta iD, Isabella L Augusto iD, Ana Clara M Montuori-Andrade iD, Lívia Cristina R Teixeira iD und 7 weitere

British Journal of Pharmacology · 2025-08 · 182 (15) · 3539-3558

DOI: 10.1111/bph.70026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025-04. Verfasst von Edvaldo S Lara und 18 weiteren Autor:innen. Beteiligte Einrichtung: Signaling in Inflammation Lab., Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo …. Hauptthemen laut MEDLINE: Annexin A1, Receptors, Formyl Peptide, Escherichia coli Infections, Lung. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Pró-Reitoria de Pesquisa, Universidade Federal de Minas Gerais, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Gram‐negative bacteria are the main causes of pneumonia in the nosocomial environment. Inflammation triggered during pneumonia is necessary for bacterial clearance but must be spatially and temporally regulated to prevent further tissue damage and bacterial dissemination. Emerging data shows that annexin A1 (ANXA1) signalling through its receptor FPR2 promotes host resistance and resilience in preclinical models of infectious disease. Experimental Approach Using a mouse model of Escherichia coli ‐induced pneumonia, the role of ANXA1/FPR2 on key steps of inflammation resolution was evaluated. Key Results Anxa1 and Fpr2/3 knockout mice, intranasally infected with E. coli , exhibited exacerbated neutrophilic inflammation, higher bacterial dissemination, decreased neutrophil apoptosis/efferocytosis counts in the airways and higher levels of inflammatory cytokines/chemokines coupled to marked lung damage and dysfunction, as compared to WT mice. Treatment of WT‐infected mice with the ANXA1 peptidomimetic, annexin I‐(2‐26), decreased inflammation, increased apoptosis/efferocytosis of neutrophils and improved bacterial clearance in the airways and lungs, resulting in an improvement of lung function. The pan‐caspase inhibitor Z‐VAD‐FMK prevented annexin I‐(2‐26)‐induced resolution of the neutrophilic inflammation, underlining neutrophil apoptosis as the main mechanism for annexin I‐(2‐26) promotion of resolution of E. coli pneumonia. In addition, annexin I‐(2‐26) treatment increased the numbers of airway macrophages of infected mice and promoted macrophage phagocytosis of E. coli in vitro . Conclusions and Implications In summary, these findings highlight the role for ANXA1/FPR2 pathway as a nonredundant resolution mechanism for E. coli ‐ induced pneumonia and demonstrate that annexin I‐(2‐26) as a potential host‐directed therapeutic approach to treat infectious lung diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Annexin A1Receptors, Formyl PeptideEscherichia coli InfectionsLungLeukocytesPneumoniaPneumonia, BacterialAnimalsMice, KnockoutMiceMice, Inbred C57BLEscherichia coliSignal TransductionApoptosisMaleInflammationPhagocytosisDisease Models, AnimalNeutrophilsPeptides

Stichwörter der Autor:innen

FPR2annexin A1inflammationpneumoniaresolution of infection

Substanzen

Annexin A1Receptors, Formyl Peptideformyl peptide receptor 2, mouseannexin A1, mouseannexin A1 peptide (2-26)Peptides

Autor:innen und Institutionen

  • Signaling in Inflammation Lab., Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Programa de Pós-Graduação em Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Centro de Pesquisa e Desenvolvimento de Fármacos, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Laboratório de Imunologia e Mecânica Pulmonar, Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Pulmonary and Critical Care Medicine Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Edvaldo S Lara, Antônio Felipe S Carvalho, Camila Cardoso, Isabella Zaidan, Laís C Grossi, Fernanda S Carneiro, Erick Bryan S Lima, Adelson Heric A Monteiro, Rodrigo S Caixeta, Isabella L Augusto, Ana Clara M Montuori-Andrade, Lívia Cristina R Teixeira, Celso M Queiroz-Junior, Remo C Russo, Mauro Perretti, Vivian V Costa, Mauro M Teixeira, Luciana P Tavares, Lirlândia P Sousa

Förderung

  • Pró-Reitoria de Pesquisa, Universidade Federal de Minas Gerais
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • National Institute of Science and Technology in Dengue and Host-Pathogen Interactions
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Zitieren

APA

Lara, E. S., Carvalho, A. F. S., Cardoso, C., Zaidan, I., Grossi, L. C., Carneiro, F. S., Lima, E. B. S., Monteiro, A. H. A., Caixeta, R. S., Augusto, I. L., Montuori-Andrade, A. C. M., Teixeira, L. C. R., Queiroz-Junior, C. M., Russo, R. C., Perretti, M., Costa, V. V., Teixeira, M. M., Tavares, L. P., & Sousa, L. P. (2025). Annexin A1/FPR2 pathway modulates leukocyte function during Escherichia coli ‐induced pneumonia to promote resolution of inflammation and restores lung function. British Journal of Pharmacology, 182(15), 3539-3558. https://doi.org/10.1111/bph.70026

Vancouver

Lara ES, Carvalho AFS, Cardoso C, Zaidan I, Grossi LC, Carneiro FS, et al. Annexin A1/FPR2 pathway modulates leukocyte function during Escherichia coli ‐induced pneumonia to promote resolution of inflammation and restores lung function. British Journal of Pharmacology. 2025;182(15):3539-3558. doi:10.1111/bph.70026

BibTeX
@article{Lara2025,
  author = {Lara, Edvaldo S and Carvalho, Antônio Felipe S and Cardoso, Camila and Zaidan, Isabella and Grossi, Laís C and Carneiro, Fernanda S and Lima, Erick Bryan S and Monteiro, Adelson Heric A and Caixeta, Rodrigo S and Augusto, Isabella L and Montuori-Andrade, Ana Clara M and Teixeira, Lívia Cristina R and Queiroz-Junior, Celso M and Russo, Remo C and Perretti, Mauro and Costa, Vivian V and Teixeira, Mauro M and Tavares, Luciana P and Sousa, Lirlândia P},
  title = {Annexin A1/FPR2 pathway modulates leukocyte function during Escherichia coli ‐induced pneumonia to promote resolution of inflammation and restores lung function},
  journal = {British Journal of Pharmacology},
  year = {2025},
  volume = {182},
  number = {15},
  pages = {3539--3558},
  doi = {10.1111/bph.70026}
}
Kostenlos starten →